Amarin (AMRN) Sees Morning Upside
Tweet
Share
E-mailGet Alerts AMRN Hot Sheet
Join SI Premium – FREE
Biotech traders are all over Amarin Corporation plc (Nasdaq: AMRN) this morning. Shares are up 4.5 percent on active pre-open volume.
Shares will be in focus over the next month or so with a FDA PDUFA date of July 26, 2012 for AMR101.
Shares will be in focus over the next month or so with a FDA PDUFA date of July 26, 2012 for AMR101.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amarin to Report Second Quarter 2026 Financial Results and Host Conference Call on July 29, 2026
- Trump on Iran: don't like giving deadlines
- NVIDIA, Kawasaki Heavy to build shipyard in Japan - Nikkei
Create E-mail Alert Related Categories
Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
